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Summary
Objective: The Western Ontario and McMaster Universities (WOMAC) Osteoarthritis (OA) Index is a tested questionnaire to assess
symptoms and physical functional disability in patients with OA of the knee and the hip. We adapted the WOMAC for the Italian language
and tested its metric properties in 304 patients with symptomatic OA of the knee.
Methods: Three hundred and four consecutive patients, attending 29 rheumatologic outpatient clinic in northern, central, and southern Italy,
were asked to answer two disease-specific questionnaires (WOMAC and Lequesne algofunctional index) and one generic instrument
(Medical Outcomes Study SF-36 Health Survey—MOS SF-36). A sample of 258 patients was readministered the WOMAC 7–10 days after
the first visit and the structured interview, which also assessed demographic and other characteristics. Internal consistency was assessed
using Cronbach’s alpha, reliability using intraclass correlation coefficients (ICCs), and construct and discriminant validity using Spearman’s
correlations, Wilcoxon rank sum test, and Kruskal–Wallis test.
Results: All WOMAC subscales (pain, stiffness, and physical function) were internally consistent with Cronbach’s coefficient alpha of 0.91,
0.81, and 0.84, respectively. Test–retest reliability was satisfactory with ICCs of 0.86, 0.68, and 0.89, respectively. In comparison with the
SF-36, the expected correlations were found when comparing items measuring similar constructs, supporting the concepts of convergent
construct validity. Very high correlations were also obtained between WOMAC scores and Lequesne OA algofunctional index. WOMAC
physical function, but not WOMAC stiffness and pain subscales, was weakly associated with radiological OA severity (P0.03). Also,
WOMAC pain score was inversely correlated (P0.01) with years of formal education. Examination of discriminant validity showed that the
scores on the WOMAC and SF-36 followed hypothesized patterns: the WOMAC discriminated better among subjects with varying severity
of knee problems, whereas the SF-36 discriminated better among subjects with varying levels of self-reported health status and comorbidity.
Conclusion: The Italian version of WOMAC is a reliable and valid instrument for evaluating the severity of OA of the knee, with metric
properties in agreement with the original, widely used version.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Introduction
Osteoarthritis (OA) is a major cause of musculoskeletal
pain, the single relevant cause of disability and handicap
from arthritis, and an important community healthcare
burden, in lost time at work and early retirement1–4. The
knee joint is a common site of OA5,6, and subjects with
knee OA exhibit a characteristic pattern of decrements in
function, generally concerning mobility, transfer from
seated or supine position to standing, and activities of daily
living (ADLs) involving the lower extremities1,7. The clinical
metrology of OA is complex because, like other conditions,
such as rheumatoid arthritis, ankylosing spondylitis, and
fibromyalgia, there are few constants in the clinical presen-
tation. Furthermore, OA may be symptomatic or not, and
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the associated radiographs either normal or abnormal. In
this context, it is necessary to identify valid and acceptable
outcome measures in order to correctly evaluate the effec-
tiveness of the therapy in OA. Such measures should
benefit not only clinicians managing OA and purchasers of
health care for this condition, but also, ultimately, the
patients through improved forms of treatment. It is increas-
ingly recognized that a key outcome measure for any
health-care intervention for OA, as for many other con-
ditions, is a change in health-related quality of life (HR-
QoL)8,9. Quality of life has multiple dimensions, and in
recent years, researchers and clinicians have produced
several generic and disease-specific questionnaires to
measure it10–12. Generic measures that have been exten-
sively tested and shown to be reliable and valid in different
populations and for a variety of uses include the SF-3613,
the Sickness Impact Profile14, the Nottingham Health
Profile15, and the EuroQuol16. The most widely used
condition-specific instruments for the assessment of hip or
knee OA is the Western Ontario and McMaster Universities
(WOMAC) OA Index17,18, which is recommended by the
Outcome Measures in Rheumatoid Arthritis Clinical Trials
(OMERACT)19,20. The WOMAC scale was designed to
measure dysfunction and pain associated with OA of the
lower extremities by assessing 17 functional activities, five
pain-related activities, and two stiffness categories21. This
self-assessment multidimensional instrument has been
well studied, and many of its psychometric properties are
known19. However, to enable comparison between assess-
ments made in different countries, this questionnaire needs
not only to be translated, but also to be adapted for use in
different cultures. We report on the linguistic validation of
an Italian version of WOMAC OA Index, and present data
on its metric properties.
Methods
PATIENTS
Recruitment of patients
In this cross-sectional study, the WOMAC was adminis-
tered to 304 outpatients with symptomatic tibiofemoral OA
of the knee, fulfilling the American College of Rheumatol-
ogy (ACR) criteria for knee OA22, enrolled in 29 rheumato-
logic centers in northern, central, and southern Italy. The
multicentric feature of this validation study is an important
issue in that the centers were chosen to minimize any
possible bias due to different cultural, semantic, and demo-
graphic factors. During the clinic visit, each patient under-
went a complete assessment according to a standard
protocol. A sample of 258 patients was readministered the
WOMAC 7–10 days after the first visit to evaluate the
instrument’s test–retest reliability. We based classification
of knee radiographs on the standard Kellgren/Lawrence
(K/L) criteria23 (graded 0–4, where 0, absence of any sign
of radiological OA (ROA); 1, possible osteophytes only; 2,
definite osteophytes and possible joint space narrowing; 3,
moderate osteophytes and/or definite joint space narrow-
ing; and 4, large osteophytes, severe joint space narrow-
ing, and/or bony sclerosis). ROA is defined as a score
higher than 2, and severe ROA as a score higher than 3 in
the left and/or right joint. Radiographs used in this study
were generally obtained within 1 year of the date of the
questionnaire assessments24. To be eligible, all patients
had to be symptomatic, requiring either nonsteroidal anti-
inflammatory drugs (NSAID) or a pure analgesic, or both to
control their pain. The knee designated as the ‘study joint’
was the primary source of pain or disability in the lower
extremity. Exclusion criteria were as follows: concurrent
systemic inflammatory rheumatic disease; medical comor-
bidity that would render the patient unable to participate
fully in study procedures (e.g., terminal conditions, such as
end-stage renal disease, heart failure, or malignancy);
alcohol abuse or a psychiatric disorder; and previous or
planned knee arthroplasty of the study joint. All centers
had approval from their respective ethics committees. All
patients provided informed consent.
Background and illness-related variables
Demographic and socio-economic information were
assessed from the interview with patient. Age is given in
years. Educational level was separated into three cat-
egories based on the Italian school system: 1, primary
school; 2, secondary school; and 3, high school or univer-
sity. Marital status was recorded in two categories: 1, living
together and 0, living alone. The body mass index (BMI;
body weight divided by the square of the height) was used
to assess overweight, which is a known risk factor for OA of
the knee. Being overweight was defined as having a BMI of
26–29 kg/m2 and being obese having a BMI >30 kg/m2. In
all patients was assessed the presence of comorbidities.
These were ascertained through patient’s self-reports
using additional questions probed for the presence of nine
specific comorbid conditions (hypertension, myocardial
infarction, lower extremity arterial disease, major neuro-
logic problem, diabetes, gastrointestinal disease, chronic
respiratory disease, kidney disease, and poor vision). The
total comorbidity score was the sum of the comorbidity
conditions (0, not present; 1, present). This score ranged
from 0 to 9.
MEASURES
WOMAC
The WOMAC is a disease-specific self-report multi-
dimensional questionnaire assessing pain, stiffness, and
physical functional disability17,18. This index has gained
growing acceptance in OA assessment since its introduc-
tion in 1986. The pain dimension or scale includes five
items asking pain at activity or rest. The stiffness dimension
includes two questions. The function dimension explores
the degree of difficulty in 17 activities. The original WOMAC
is available in two formats, visual analog scales (VAS) and
five Likert boxes, with similar metric properties17,18,21. The
translation of the WOMAC in Italian format (for a descrip-
tion of the formats see Appendix) was done by two bilingual
researchers aware of the objective of the questionnaire. It
was then translated back into English by two different
bilingual persons, who had no prior knowledge of the
instrument. No major cultural adaptations were made. In
this study, the Italian WOMAC was used in its VAS format,
and all 24 items are rated by the subject on a 100 mm VAS
ranging from 0 (indicating no pain, stiffness, or difficulty) to
100 (indicating extreme pain, stiffness, or difficulty). The
range of the WOMAC scores is: pain (0–500); stiffness
(0–200), and function (0–1700).
SF-36
The SF-36 is a generic instrument with scores that are
based on responses to individual questions, which are
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summarized into eight scales, each of which measures a
health concept13. These scales include function domains
and aspects of well being as follows: physical function; role
limitations due to physical problems; body pain; vitality or
energy level; role limitations due to personal or emotional
problems; mental health; social function; and general
health perception13. The physical function scale consists of
10 items that ask about involvement in a range of activities,
such as running, playing, lifting heavy objects, climbing
stairs, walking, and bathing or dressing oneself. Respond-
ents are asked to rate on a three-point scale the extent to
which their health limited their ability to engage in the
various activities over the past 4 weeks (1, limited a lot; 2,
limited a little, and 3, not limited at all). The pain scale
consists of two items asking patient to rate pain severity
over the past week on a five-point scale. The psychological
and social function scales include five and two items,
respectively. For each of the SF-36 scales, necessary
items are recorded so that higher values indicate better
health, and are then summed. The summed scores are
transformed to a 0–100 scale, following its designated
scoring algorithm, with higher scores reflecting better qual-
ity of life. These eight scales, weighted according to nor-
mative data, are scored from 0 to 100, with higher scores
reflecting better quality of life13. The SF-36 survey also
includes a single-item measure of health transition, which is
not used to score any of the eight multi-items scales. The
SF-36 has been validated for use in Italy25, and it can be
completed within 10 min by most people. Recently, the
originators of the SF-36 have developed algorithms to
calculate two psychometrically based summary measures:
the Physical Component Summary Scale Score (PCS) and
the Mental Component Summary Scale Score (MCS)26,27.
The PCS and MCS provide greater precision, reduce the
number of statistical comparisons needed, and eliminate
the floor and ceiling effects noted in several of the
subscales28–30. For the analysis, body pain, physical
functioning, and MCS were selected.
Lequesne algofunctional index
The index contain three components: pain or discomfort;
maximum distance walked; and ADLs31,32. Points are
allocated according to response so that higher values
indicate greater severity. The theoretical maximum score
is 24. Although the metric properties of the Lequesne
algofunctional index have been established31,32, separate
subsections have not been validated for independent
application33. The Lequesne OA index was proposed as an
interview technique33.
Statistical analysis
Patients were included in any analysis only when rel-
evant data were complete, using two statistical packages
(Statistica for Macintosh, StatSoft, Inc., USA, and MedCalc
version 6 for Windows, MedCalc Software, Belgium). Para-
metric techniques may be applicable for certain ordinal
level data; however, our data were generally not normally
distributed (Kolmogorov–Smirnov test for normal distri-
bution), and therefore, the use of nonparametric techniques
provided a more conservative estimate of statistical signifi-
cance. Where appropriate, median and interquartile ranges
are presented as well as means and standard deviations
(SD). We also calculated the percentage of the sample
achieving the lowest (floor effect) and highest (ceiling
effect) possible WOMAC scores.
Reliability
Controversy exists over the relative merits of test–retest
and internal consistency methods of assessing reliability34.
In this study, the test–retest reliability of the WOMAC was
analyzed using intraclass correlation coefficients (ICCs).
The ICC reflects both systematic and random differences in
test scores35. Values of ICC thus vary from 1 (perfectly
reliable) to 0 (totally unreliable). The ICC was chosen in
preference to the Pearson correlation, which may over-
estimate reliability34. We also assessed reliability in terms
of internal consistency of the WOMAC subscales (pain,
stiffness, and function). Internal consistency measures the
extent to which items within a scale are correlated with
each other35. If the WOMAC is internally consistent in the
OA population, we would expect items within the individual
scales (or dimension) to be highly correlated with each
other. The Cronbach alpha statistic36 is used to estimate
the average of the correlations between items within a
dimension. According to Steiner and Norman37, a value of
0.8 is usually regarded as acceptable.
Validity
Establishing the criterion or content validity of an instru-
ment claiming to measure HRQoL is difficult, as there are
no established gold standards for comparison. Evidence for
construct validity can only be accumulated by a priori
hypothesized patterns of associations with other validated
instruments38. In this study, the construct validity was
examined in terms of convergence between similar dimen-
sions of the SF-36 questionnaire, Lequesne algofunctional
index and global health status. Correlations were made
using Spearman’s rank method. To investigate a possible
influence of patient characteristics, such as age, sex,
marital status, level of education, BMI, and radiographic OA
severity on the WOMAC, the associations between the
WOMAC subscales and these characteristics were quanti-
fied by Wilcoxon rank sum test and by Kruskal–Wallis
one-way analysis of variance. Discriminant validity was
assessed by comparing WOMAC scores in patients with
and without other health conditions. These were ascer-
tained through patient’s self-reports using nine additional
questions, also included in the questionnaire. For each
dimension, the Spearman’s correlation coefficient was
calculated to assess how well each dimension correlates
with the number of comorbidities.
Results
COHORT DISTRIBUTION
Table I shows the main socio-demographic character-
istics of patients (age, sex, disease duration, BMI, the
number and percentage of patients with K/L rating score,
the number of comorbid conditions, and educational level).
The mean age of the 304 patients examined was 65.7±9.3
years (range 50–82). Of the total respondents, 214 were
females (70%), 90 were males (30%). The mean duration
of OA was 9.5±7.9 years. The school education level was
generally low: 62.5% had received only a primary school
education and only 16.5% had received a high school
education. The majority of patients (84.5%) were married
and lived with the family; up to 46.5% of the patients were
housewives. BMI, indicative of overweight, was recorded
for 68% of the patients examined. Of the 304 subjects
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enrolled, 174 (57.2%) reported one or more medical co-
morbidities, mostly cardiovascular (29.2%), respiratory
(14.5%), and metabolic (11.5%) disorders. All subjects
were affected by OA of the knee: 91% of them presented
primary OA, with a radiological severity prevalently of
second and third degree of Kellgren’s scale23 (34 and 44%,
respectively).
DISTRIBUTION OF SCORES
Table II summarizes the mean, SD, median values,
and interquartile for each of the aspects of health status
covered by the WOMAC and SF-36, and for Lequesne
algofunctional index. The distribution of the scores in the
WOMAC (pain, stiffness, physical function, and overall
scores) are presented in Fig. 1. The bar on the left of each
graph represents the number of subjects with a score of 0
(floor effect); the bar on the right represents the number of
subjects with a maximum possible score (ceiling effect).
The WOMAC had negligible floor and ceiling effects in
patients with OA of the knee.
RELIABILITY
Of the 304 patients enrolled in the study, 258 completed
WOMAC twice within the stipulated 7 to 10 days with a
mean of 8.7±2.1 days. The ICCs of the three dimensions
pain, stiffness, and physical function were 0.86, 0.68, and
0.89, respectively. Cronbach’s alpha coefficients were
acceptable for all three dimensions of the WOMAC, accord-
ing to standards recommended by Steiner and Norman37.
Cronbach’s alpha for the three dimensions pain, stiff-
ness, and physical function were 0.91, 0.81, and 0.84,
respectively.
CONSTRUCT VALIDITY
In testing for convergent validity between instruments
(Table III), we found that correlation coefficients for
the comparable dimension of the WOMAC and the SF-36
(pain and physical) were −0.611, and −0.706, respectively
(P<0.0001). Figure 2 shows a scatter plot of patient’s
WOMAC function against the physical functioning score of
the SF-36. For the overall scores, the Spearman correlation
coefficient is −0.664 (P<0.0001). We also investigated the
relationship of WOMAC scores with SF-36 MCS. As shown
in Table III, the strongest correlations were between the
WOMAC pain and physical scores and MCS (−0.584 and
−0.567, respectively). The WOMAC subscales and overall
score were highly (0.585 to 0.771; P<0.0001) correlated
with Lequesne algofunctional index (Fig. 3). All three
WOMAC dimensions correlated significantly with each
other (P<0.0001). The strongest correlation was between
physical function and pain (0.824; P<0.0001). No signifi-
cant difference was observed in the comparison between
the two subgroups of patients stratified by age (under 65
years vs 65 years or more), marital status (living together
vs living alone), and BMI (BMI of 26–29 kg/m2 vs
BMI>30 kg/m2). Women tended to report higher WOMAC
score than men, but this was significant only for the
WOMAC pain score (women: 211.1±112.1 vs men:
179.6±97.1; P0.04). Also, WOMAC pain score, but not
WOMAC stiffness and physical function scores was in-
versely correlated with years of formal education. Stratifi-
cation into three categories confirmed that increasing
education was associated with lower pain scores (WOMAC
pain scores: primary school=206.2±111.1; secondary
Table I
Socio-demographic and clinical characteristics of the study group
(N304)
Age, years
Mean (SD) 65.7 (9.3)
Range 50–82
Sex (%)
Male 30
Female 70
Duration of OA, years
Mean (SD) 9.5 (7.9)
Range 1–19
BMI
Mean (SD) 33.8 (11.3)
Range 20.1–49.8
K/L rating score, no. (%)
Grade 1 26 (8.5)
Grade 2 102 (33.5)
Grade 3 136 (44.8)
Grade 4 40 (13.2)
Number of comorbid conditions, no. (%)
0 130 (42.8)
1 91 (29.9)
2 38 (12.5)
3 20 (6.6)
4 or more 25 (8.2)
Educational level, no. (%)
Primary school 190 (62.5)
Secondary school 64 (21.0)
High school/university 50 (16.5)
BMI, body mass index (body weight divided by the square of the
height).
Table II
Descriptive statistics and features of score distributions for health
status measures in OA patients (N304)
Mean
score
SD Median Interquartile
(25th–75th)
WOMAC subscales
Pain 195.7 110.4 196 101–277
Stiffness 77.4 51.2 70 30–119
Physical function 751.4 381.6 762.5 450–1050
WOMAC overall score 1025.8 519.8 1042.5 584–1412
SF-36 subscales
Physical function 48.1 23.1 45 30–65
Role limitations
(physical)
33.5 37.5 25 10–75
Body pain 37.5 17.5 41 22–50
Energy/vitality 50.4 20.6 50 35–67
Role limitation
(emotional)
51.3 41.3 50 12–90
Mental health 58.2 26.1 60 40–78
Social function 60.1 24.8 62 40–87
General health
perceptions
51.1 42.6 50 32–67
SF-36 PCS 40.8 22.8 39 24–58
SF-36 MCS 58.2 26.1 60 40–78
Lequesne
algofunctional index
11.7 4.9 12 7–15
PCS, Physical Component Summary Scale Score; MCS, Mental
Component Summary Scale Score.
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school=189.4±112.2; high school/university=157.6±102.5;
Kruskal–Wallis test: H8.91; P0.01) (Fig. 4). There were
no significant differences in self-reported symptoms (pain
and stiffness) by K/L scores, whereas WOMAC physical
function dimension was weakly associated with radiological
severity (K/L grade 1=609.2±349.2; grade 2=745.4±372.7;
grade 3=728.1±357.1; grade 4=950.6±432.5; Kruskal–
Wallis test: H7.58; P0.03).
DISCRIMINANT VALIDITY
Discriminant validity was assessed by comparing the
WOMAC and SF-36 dimensions (pain, physical, and
overall scores) in patients with and without other health
conditions. For each dimension, the Spearman correlation
coefficient was calculated to assess how well score cor-
relate with the number of comorbid conditions. Positive
correlations are expected in WOMAC, indicating that sub-
jects with more comorbidities have higher scores than
subjects with fewer comorbidities, while negative correla-
tions are expected in SF-36, indicating that subjects with
more comorbidities would have lower (worse) scores than
subjects with fewer comorbidities. Correlations closer to 1
in absolute value indicate stronger correlation between the
score and the number of comorbidities, and, therefore,
more discriminatory ability. The SF-36 scores show a better
Fig. 1. Distribution of the scores in the WOMAC (pain, stiffness, physical function, and overall scores).
Table III
Convergent validity analysis: correlation matrix of WOMAC vs SF-36 dimensions and Lequesne algofunctional index (N304)
WOMAC pain WOMAC stiffness WOMAC physical function WOMAC overall score
SF-36
Body pain −0.601 −0.462 −0.590 −0.608
Physical function −0.611 −0.544 −0.706 −0.702
SF-36 MCS −0.584 −0.403 −0.567 −0.572
SF-36 overall score −0.608 −0.515 −0.650 −0.664
Lequesne algofunctional index 0.705 0.585 0.756 0.771
MCS, Mental Component Summary Scale Score.
All correlations were significant at P<0.0001 (Spearman rank coefficients).
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gradient with comorbidities than the WOMAC. For pain
scores, the Spearman correlation between number of
comorbid conditions and the WOMAC and SF-36 scales,
respectively, are 0.235 (P0.0001) and −0.307
(P<0.0001). For the physical function score, the Spearman
correlation between the number of comorbidities and the
WOMAC and SF-36 are, respectively, 0.195 (P0.0005)
and −0.298 (P<0.0001). For the WOMAC and SF-36 over-
all scores, the Spearman correlation are, respectively,
0.211 (P0.0003) and −0.312 (P<0.0001). Figures 5 and 6
shown the WOMAC and SF-36 overall scores by number of
comorbidities.
Discussion
OA of the knee has been identified as one of the most
prevalent chronic disorders affecting adults and a major
cause of discomfort (pain and stiffness) and physical
disability that results in extensive use of health-care
resources1–4,39. In spite of the high prevalence of OA,
presently, a few of validated health status measures exist
for the evaluation of patients with OA, either in clinical
practice or in clinical trials40. The WOMAC is a widely used
and validated three-dimensional disease-specific, self-
administered, health status measure assessing pain, stiff-
ness, and function in patients with OA of the knee or
hip17,18. Indicative of its widespread use in multicenter trials
are its use by several groups of investigators and its
incorporation in a set of guidelines for outcome measure-
ment in trial of so-called slow acting drugs in OA
(SADOA)41, and in the core measures developed at the
OMERACT III conference19 and subsequently ratified by
the OA Research Society International Task Force on
Fig. 2. Scatter plot of patient’s WOMAC function against the
physical functioning score of the SF-36. For descriptive linear
regression line of ‘best fit’ purposes has been superimposed.
Fig. 3. Scatter plot of patient’s overall WOMAC score against the
score of the Lequesne algofunctional index. For descriptive linear
regression line of ‘best fit’ purposes has been superimposed.
Fig. 4. Median WOMAC pain score by educational level (1, primary
school; 2, secondary school; and 3, high school or university). The
box plots provides information on the symmetry of a distribution, on
the numerical measures of central tendency, and on the variability
and spread of data in the tails of a distribution. The box contains
the median values (represented by a horizontal line within the box),
25th and 75th percentiles, and wiskers representing the 10th and
90th percentiles. Kruskal–Wallis test was carried out across all
three groups (P0.01).
Fig. 5. Mean and SD of WOMAC overall scores by number of
comorbidities.
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clinical trials40. To enable comparison between assess-
ments made in different countries, these measures need
not only be translated, but also adapted for use in different
cultures. The results of the present study show that the
Italian version of WOMAC is a reliable and valid instrument
for evaluating the severity of OA of the knee, with psycho-
metric properties in agreement with the original widely used
version.
Reliability was assessed in terms of internal consistency
(Cronbach’s alpha coefficient) and test–retest reliability
(ICC analysis). Cronbach’s alpha coefficients were accept-
able for all three dimensions of the WOMAC, according to
standards recommended by Steiner and Norman37; this
indicates that each domain addressed a somewhat differ-
ent aspect of functional disability. The ICCs of the WOMAC
stiffness subscale was lower (0.68) than for pain (0.86) and
physical function (0.89) subscales. This was expected,
since similar findings have been reported for the original
version17,18, the German version42, and the Swedish
version43. For aggregate analysis, however, it is claimed
that a reliability of >0.50 may be acceptable with a large
sample size44. However, ICC analysis does result in lower
values compared with the Pearson equivalent, as ICCs
account for any additive or multiplicative element45. Fur-
thermore, the WOMAC stiffness subscale is derived from
only two scores, whilst the WOMAC pain and physical
function scores are a mean of 5 and 17 VAS ratings,
respectively. The inclusion of a greater number of sub-
scales necessarily results in a more stable score, less
susceptible to measurement error. This possibility partly
explains the superior reliability demonstrated by the
WOMAC pain and physical function dimensions29. Modest
reliability may, however, just reflect fluctuating symptoma-
tology characteristic of knee OA, as WOMAC asks the
responders to consider their ‘health state in the past 2
days’. In contrast, the SF-36 asks responders to consider
‘the past 4 weeks’, potentially allowing greater 1 week
test–retest reliability compared with WOMAC29.
Construct validity was examined in terms of the conver-
gence between like dimensions of the self-administered
WOMAC, and of the SF-36. A study of the correlation of like
dimensions across the two health status instruments found
the expected convergence. While WOMAC and SF-36
address symptoms and functional disability in separate
scales, which may be aggregated into a composite index,
the Lequesne OA algofunctional index directly aggregate
symptoms and function, which are not graded separately. A
very high correlation between WOMAC scores and
Lequesne OA algofunctional index makes the Lequesne
index redundant. In this study, as in others21,24, a strong
association was also noted between WOMAC subscale
scores and patient’s emotional state (SF-36 MCS). The fact
that the WOMAC is sensitive to psychosocial factors is not
to be attributed to the instrument itself. Self-report instru-
ments is sensitive to these factors and, indeed, such
factors contribute to the actual pain and physical impair-
ment reported by patients29,46–50. If, however, a patient’s
emotional state markedly influence pain and physical
health status perception, the resultant random measure-
ment error would restrict the validity of the WOMAC or
other self-report questionnaires to only relatively large
studies29. In this study, we also investigated the relation-
ship between WOMAC scores and the main socio-
demographic characteristics (age, sex, disease duration,
BMI, and educational level) and radiology K/L rating. No
significant difference was observed in the comparison
between the two subgroups of patients stratified by age
(under 65 years vs 65 years or more). Previous re-
searchers have failed to find an association between age
and presence48,51,52 or severity of pain and physical func-
tion in OA46,47,53. Female sex has been associated with
increased reporting of knee pain in some community
studies50,52,53, but not in others51. Our results confirm
earlier observations50,52,53 that females tended to report
greater severity of knee pain on WOMAC subscale.
While BMI is clearly a strong risk factor for radiographic
knee OA6, its relationship with pain reporting is less
certain47,48,53. We found that BMI was not associated with
WOMAC dimension subscales. Years of formal education
have been reported to be a risk factor for presence of knee
pain in the community53–55. Previously50, we found educa-
tion to be related to mobility level, arm function, pain, and
work as measured by Arthritis Impact Measurement Scales
(AIMS2) subscores. We confirm a significant relationship
between knee pain severity by WOMAC and level of formal
education, suggesting that formal education should be
included as a variable in clinical studies of knee OA. The
mechanism by which education influences pain severity is
unclear, but may be related to enhanced self-efficacy and
sense of control allowing the patient to take advantage of a
greater number of pain-reducing modalities. In this study,
as in others24,42,43,46–49,55–58, we found that radiographic
severity as measured by K/L grade is not associated with
pain severity. There are limitations to use radiographs for
ascertainment of OA. Recent evidence suggests that radio-
graphs may underestimate the true prevalence of OA59.
This may result in misclassification of patients as to
disease6. In addition, early disease may not be detectable
by radiography, and some pathologic processes such as
osteophytes may not represent progressive disease, thus
potentially resulting in misclassification. Also, self-reported
knee pain or physical function, which are a common
complaint of elderly people, may not be due to a pathologi-
cal process of the knee but to pain from hip or back
disease, thus confounding the analyses49. Other prevalent
causes of mobility restriction were the presence of prob-
lems with the cardiovascular and respiratory systems.
Several studies, using data from the National Health
Interview Survey Supplement on Aging60–62 and Longitudi-
nal Supplement on Aging63, the Framingham Study1, the
Ontario Health Survey64, and the Women’s Health and
Aging Study65 have demonstrated the role of comorbidities
Fig. 6. Mean and SD of SF-36 overall scores by number of
comorbidities.
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in the relationship between OA and disability. The results of
the discriminant validity, assessed by comparing the
WOMAC and SF-36 dimensions in patients with and with-
out other health conditions pointed out that the SF-36
scores show a better gradient with comorbidities than that
of the WOMAC on all three dimensions. This is not surpris-
ing since the WOMAC is designed as a measure of
functional disability, rather than general health status,
whereas, the SF-36 is a measure of general health status,
which includes an assessment of functional disability
and also assesses emotional functioning and roles, social
functioning, and energy.
In conclusion, the results reported in this study confirm
the reliability and validity of the Italian version of WOMAC
in patients with OA of the knee. Collection information on
health status using questionnaires such as WOMAC and
SF-36 was acceptable to patients, though unfamiliar to
them. Informally, patients reported a preference for the
WOMAC because they found it easier to complete.
Although we have not yet studied the sensitivity of
WOMAC to change (i.e., responsiveness), this study has
implications for the conduct of future clinical trials in OA.
We are currently conducting further studies on the re-
sponsiveness of WOMAC against several other health
status instruments.
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Appendix: The 24 items included in the
Italian-WOMAC questionnaire
I. DOLORE
Che intensita` prova:
1. Camminando su una superficie piana
2. Salendo o scendendo le scale
3. A letto, durante il sonno notturno (interferisce con il
sonno)
4. Da seduto o in posizione supina
5. Stando in piedi, in posizione eretta
II. RIGIDITA’
Quanto e` intensa la Sua rigidita`:
6. Subito dopo il risveglio al mattino
7. Dopo essere stato seduto, sdraiato oppure dopo aver
riposato, piu` tardi nel corso della giornata
III. FUNZIONE FISICA
Qual e` il grado di difficolta` che avverte nel:
8. Scendere le scale
9. Salire le scale
10. Alzarsi da seduto
11. Stare in piedi
12. Piegarsi verso il pavimento (per raccogliere un oggetto)
13. Camminare su una superficie piana
14. Entrare ed uscire da una macchina o salire e scendere
da un autobus
15. Andare a far spese
16. Mettersi i calzini o le calze
17. Alzarsi dal letto
18. Togliersi i calzini o le calze
19. Stare sdraiato a letto
20. Entrare ed uscire dalla vasca da bagno
21. Stare seduto
22. Sedersi o alzarsi dal water
23. Fare lavori domestici pesanti
24. Fare lavori domestici leggeri
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